Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Entecavir (Baraclude) – Oral Antiviral Drug for Hepatitis-B Infection

Drug (Brand / Generic)

Entecavir / Baraclude

Company / Licensee

Bristol-Myers Squibb

Therapy Class

Antiretroviral

Product Description

Nucleoside analog

Current Indication

Chronic Hepatitis-B infection

Market Sector

Immunology

Current Status

Approved in the US, India, Australia, China, Indonesia, Philippines and Singapore
Expand
Close
Close
Close

Go Top